Psychedelic therapy isn’t that neglected—it’s in a stage 3 clinical trial and has had a major book published on it already, and plenty of mental health professionals have been covertly working on it as underground psychedelic therapists. There are so many biology PhDs already that the bigger bottleneck appears to be general research funding and FDA regulations.
Doesn’t the second sentence here cut against the first?
i.e. doesn’t “the bigger bottleneck appears to be general research funding” speak against “Psychedelic therapy isn’t that neglected”?
That’s a good catch—I was thinking of EAs pursuing positions as psychedelic therapy researchers/practitioners, but clearly you could advocate for more research funding or donate toward it as an EA project.
Doesn’t the second sentence here cut against the first?
i.e. doesn’t “the bigger bottleneck appears to be general research funding” speak against “Psychedelic therapy isn’t that neglected”?
That’s a good catch—I was thinking of EAs pursuing positions as psychedelic therapy researchers/practitioners, but clearly you could advocate for more research funding or donate toward it as an EA project.